AAOI vs REGN · rev $343.1M vs P/E 14, rev $4.29B
Applied Opt (AAOI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Applied Opt (AAOI) is a communication equipment company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AAOI revenue for 2026-06-30 was $343.1M. Net income was -$37.1M. AAOI currently screens at market cap $1.56B.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AAOI currently screens at market cap $1.56B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AAOI and REGN stock pages for the full models.
Not investment advice.